Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,010,946
  • Shares Outstanding, K 22,001
  • Annual Sales, $ 154,420 K
  • Annual Income, $ 26,910 K
  • 60-Month Beta 1.01
  • Price/Sales 6.34
  • Price/Cash Flow 26.82
  • Price/Book 3.92
Trade LMAT with:

Options Overview Details

View History
  • Implied Volatility 47.17% ( +4.35%)
  • Historical Volatility 27.85%
  • IV Percentile 43%
  • IV Rank 63.37%
  • IV High 67.17% on 05/12/22
  • IV Low 12.57% on 09/22/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 79
  • Open Int (30-Day) 79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.26
  • Number of Estimates 5
  • High Estimate 0.27
  • Low Estimate 0.25
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.69 +5.01%
on 12/29/22
47.76 -3.94%
on 01/24/23
+1.41 (+3.17%)
since 12/27/22
3-Month
41.78 +9.81%
on 10/28/22
48.73 -5.85%
on 12/13/22
-5.95 (-11.48%)
since 10/27/22
52-Week
38.32 +19.73%
on 05/09/22
56.38 -18.62%
on 08/15/22
+5.40 (+13.34%)
since 01/27/22

Most Recent Stories

More News
VREX vs. LMAT: Which Stock Is the Better Value Option?

VREX vs. LMAT: Which Stock Is the Better Value Option?

VREX : 20.78 (-0.14%)
LMAT : 45.88 (-0.15%)
Is This Small-Cap Dividend Stock a Buy?

LeMaitre Vascular isn't well-known to investors. But vascular surgeons do know the company well.

LMAT : 45.88 (-0.15%)
ESLOY vs. LMAT: Which Stock Should Value Investors Buy Now?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

ESLOY : 90.1600 (-1.51%)
LMAT : 45.88 (-0.15%)
ESLOY or LMAT: Which Is the Better Value Stock Right Now?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

ESLOY : 90.1600 (-1.51%)
LMAT : 45.88 (-0.15%)
ESLOY vs. LMAT: Which Stock Is the Better Value Option?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

ESLOY : 90.1600 (-1.51%)
LMAT : 45.88 (-0.15%)
Is This Underfollowed Dividend Stock a Buy?

The medical device maker flies under the radar of most investors.

COMP : 3.99 (+7.26%)
LMAT : 45.88 (-0.15%)
LeMaitre Vascular (LMAT) Misses Q3 Earnings and Revenue Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -10.71% and 2.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LMAT : 45.88 (-0.15%)
MRVI : 14.50 (+4.39%)
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SYK : 254.17 (+0.70%)
LMAT : 45.88 (-0.15%)
Earnings Preview: LeMaitre Vascular (LMAT) Q3 Earnings Expected to Decline

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LMAT : 45.88 (-0.15%)
BSX : 45.91 (-0.95%)
ZBH vs. LMAT: Which Stock Should Value Investors Buy Now?

ZBH vs. LMAT: Which Stock Is the Better Value Option?

ZBH : 125.88 (+0.30%)
LMAT : 45.88 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and...

See More

Key Turning Points

3rd Resistance Point 47.23
2nd Resistance Point 46.86
1st Resistance Point 46.37
Last Price 45.88
1st Support Level 45.51
2nd Support Level 45.14
3rd Support Level 44.65

See More

52-Week High 56.38
Fibonacci 61.8% 49.48
Fibonacci 50% 47.35
Last Price 45.88
Fibonacci 38.2% 45.22
52-Week Low 38.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar